Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Documentation was organized and easy to review
Economic Impact: Reduction in Healthcare Costs: An effective treatment that addresses both T1D and obesity has the potential to reduce the substantial healthcare costs associated with these conditions, particularly in terms of preventing or mitigating diabetes-related complications
Common side effects observed in monotherapy trials, similar to other GLP-1 receptor agonists, include gastrointestinal symptoms such as nausea, diarrhea, and vomiting, with most adverse events being mild to moderate in severity
Myastenia Gravis, 3
US$ 27.35
US$ 22.65
US$ 27.68
US$ 21.12
US$ 27.21
US$ 22.95
US$ 21.14
US$ 28.69
US$ 24.79
US$ 26.22
